Amendment to Investment Subadvisory Agreement Dated November 1, 2014

Amendment to Investment Subadvisory Agreement

Dated November 1, 2014

WHEREAS, Aspiriant, LLC and AQR Capital Management, LLC entered into an Investment Subadvisory Agreement dated November 29, 2012 (the “Agreement”); and

WHEREAS, the parties desire to amend the Agreement to modify Exhibit A thereto effective as of November 1, 2014.

NOW, THEREFORE, pursuant to Section 9 of the Agreement, the parties hereto agree to amend the Agreement by deleting the existing Exhibit A in its entirety and replacing it with the following:

Exhibit A

Each fee will be based on the average daily net assets of the portion of the assets of the Fund managed by the Subadviser, and calculated as described in Section 4 of the Agreement.

Name of Series & Strategy	Sub-Advisory Fee Schedule
Aspiriant Risk-Managed Global Equity Fund – “Tax Managed Global Enhanced Strategy”	Asset Level	Sub-Advisory Fee
Aspiriant Risk-Managed Global Equity Fund – “Tax Managed Emerging Defensive Strategy”	Asset Level	Sub-Advisory Fee

1

AGREED AND ACCEPTED:

AQR Capital Management, LLC
By:	/s/ Xxxxxx XxxXxxx
	Xxxxxx XxxXxxx
	Senior Counsel & Head of Registered Products
Aspiriant, LLC
By:	/s/ Rob Francais
	Rob Francais
	Chief Executive Officer

2